Daopeng Chen

Title: Daopeng Chen: Innovator in Pharmaceutical Manufacturing

Introduction

Daopeng Chen is a notable inventor based in Xuzhou, China. He has made significant contributions to the field of pharmaceutical manufacturing, particularly in the synthesis of complex compounds. His work has implications for the development of important medications.

Latest Patents

Daopeng Chen holds a patent for a process related to the manufacture of agomelatine. The patent, titled "Process for the manufacture of agomelatine and its intermediate," outlines a method that includes reacting 7-methoxy-1-naphthyl ethanol with benzenesulfonyl chloride to produce 7-methoxy-1-naphthylethyl benzene sulfonate. This compound is then reacted with potassium phthalimide to yield N-[2-(7-methoxy-1-naphthy)ethyl]phthalimide. The process further involves alkaline hydrolysis and acetylation to obtain agomelatine. This innovative approach highlights his expertise in chemical processes.

Career Highlights

Daopeng Chen is currently employed at Nhwa Pharmaceutical Corporation, where he continues to advance his research and development efforts. His work at the company has positioned him as a key player in the pharmaceutical industry, contributing to the development of new therapeutic agents.

Collaborations

Daopeng has collaborated with several colleagues, including Shixia Zhou and Yanqin Ma. These partnerships have fostered a collaborative environment that enhances innovation and efficiency in their projects.

Conclusion

Daopeng Chen's contributions to pharmaceutical manufacturing, particularly through his patent on agomelatine, demonstrate his innovative spirit and commitment to advancing medical science. His work continues to impact the industry positively.